Lim-Fat, Mary Jane http://orcid.org/0000-0002-4317-5770
Song, Kun Wei
Iorgulescu, J. Bryan
Andersen, Brian M.
Forst, Deborah A.
Jordan, Justin T.
Gerstner, Elizabeth R.
Reardon, David A.
Wen, Patrick Y.
Arrillaga-Romany, Isabel
Article History
Received: 8 January 2021
Accepted: 13 February 2021
First Online: 1 March 2021
Declarations
:
: M.J. Lim-Fat; K.W. Song; B.M. Andersen; D.A. Forst; E.R. Gerstner and I. Arrillaga-Romany report no disclosures relevant to the manuscript; J.B. Iorgulescu received support from the NIH (NCI K12CA090354) and Conquer Cancer Foundation/Sontag Foundation Young Investigator Award; J.T. Jordan received honoraria from Elsevier and Consulting for Navio Theragnostics, Recursion Pharmaceuticals, CereXis, Inc, and Health2047, Inc; D.A. Reardon received Research support (paid to DFCI) fromAcerta Phamaceuticals; Agenus; Celldex; EMD Serono; Incyte; Inovio; Midatech; Omniox; Tragara, advisory/consultation (paid to Dr. Reardon): Abbvie; Advantagene; Agenus; Amgen; Bayer; Bristol-Myers Squibb; Celldex; DelMar; EMD Serono; Genentech/Roche; Imvax; Inovio; Merck; Merck KGaA; Monteris; Novocure; Oncorus; Oxigene; Regeneron; Stemline; Taiho Oncology, Inc., Honoraria (paid to Dr. Reardon): Abbvie; Advantagene; Agenus; Bristol-Myers Squibb; Celldex; EMD Serono; Genentech/Roche; Imvax; Inovio; Merck; Merck KGaA; Monteris; Novocure; Oncorus; Oxigene; Regeneron; Stemline; Taiho Oncology, Inc; P.Y. Wen received honoraria from Agios, Astra Zeneca/Medimmune, Beigene, Celgene, Eli Lily, Genentech/Roche, Kazia, MediciNova, Merck, Novartis, Oncoceutics, Vascular Biogenics, VBI Vaccines (research support); Agios, Astra Zeneca, Bayer, Blue Earth Diagnostics, CNS Pharmaceuticals, Immunomic Therapeutics, Karyopharm, Kiyatec, Puma, Taiho, Vascular Biogenics, Deciphera, VBI Vaccines, Tocagen, Voyager, QED, Imvax, Elevate Bio (advisory board) and Merck, Prime Oncology (speaker honoraria).
: This study was conducted under a Dana-Farber/Harvard Cancer Center Institutional Review Board protocol. A waiver was granted for informed consent due to its retrospective nature.